D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 133 SEK -3.62% Market Closed
Market Cap: 2.2B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Devyser Diagnostics AB
Capital Expenditures Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Capital Expenditures
-kr32m
CAGR 3-Years
-111%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Capital Expenditures
-kr48.6m
CAGR 3-Years
-45%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Capital Expenditures
-kr8.4m
CAGR 3-Years
-66%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Capital Expenditures
-kr156m
CAGR 3-Years
-73%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Capital Expenditures
-kr3.4B
CAGR 3-Years
-9%
CAGR 5-Years
18%
CAGR 10-Years
-42%
BioArctic AB
STO:BIOA B
Capital Expenditures
-kr7.4m
CAGR 3-Years
16%
CAGR 5-Years
-12%
CAGR 10-Years
N/A

See Also

What is Devyser Diagnostics AB's Capital Expenditures?
Capital Expenditures
-32m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Capital Expenditures amounts to -32m SEK.

What is Devyser Diagnostics AB's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-45%

Over the last year, the Capital Expenditures growth was -24%. The average annual Capital Expenditures growth rates for Devyser Diagnostics AB have been -111% over the past three years , -45% over the past five years .

Back to Top